PCORI Initiatives May Support More Drug Comparisons
The Patient-Centered Outcomes Research Institute (PCORI) is launching new programs that are expected to encourage more analysis of the effectiveness of specific drugs and medical products, while also...
View ArticleClinical Ops: Highlights From this Year's SCOPE Summit
By Moe Alsumidaie. The clinical trial technological landscape continues to morph, as we are starting to see the emergence of novel technologies and techniques to enhance clinical trial strategies and...
View Article180 Diabetes Medicines in Development in the U.S.
America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development, all either...
View ArticleRisk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway
Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway By: Mukhtar Ahmed, global vice president, life sciences strategy, Oracle Health Sciences The latest news on the growing...
View ArticleBioscience Research: China to Overtake U.S. by 2020
Bioscience research in China is set to overtake the United States within the next five to ten years, according to data from search engine CiteAb. CiteAb’s founder Dr Andrew Chalmers said that data...
View ArticleClik here to view.
Pushing the Boundaries of MS Research: The Myelin Repair Foundation
R&D’s Double Header The Myelin Repair Foundation is more than just a policy precedent – it’s also emerging as the stimulus behind a future cure for MS. The decades-old movement for “patient power”...
View ArticleRebranding Risk-Based Monitoring in Clinical R&D
With all of the buzz and excitement around risk-based monitoring (RBM), one might expect that the broad adoption of this emerging clinical research paradigm is well underway. Those familiar with the...
View ArticleBig Data in the Pharma R&D Landscape
Big Data and the mindset that comes with it will have a fundamental impact on how pharmaceutical research will be conducted in the future, writes Peter Tormay. Innovation is the corner stone of the...
View ArticleThe Future of Oncology is Now
Applied Clinical Trials’ Lisa Henderson speaks to Novella Clinical CEO Richard Staub. Last August, Quintiles announced its intention to purchase Novella Clinical, specifically for its focus on small...
View ArticleCancer Medicines: Setbacks and Stepping Stones
A report released on this week by the Pharmaceutical Research and Manufacturers of America (PhRMA), “Researching Cancer Medicines: Setbacks and Stepping Stones,” highlights the number of...
View Article
